NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 206 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,277,000 | +520.4% | 48,873 | +483.1% | 0.08% | +627.3% |
| Q2 2022 | $367,000 | -72.1% | 8,382 | -54.0% | 0.01% | -78.0% |
| Q1 2022 | $1,317,000 | +168.8% | 18,209 | +201.3% | 0.05% | +163.2% |
| Q4 2021 | $490,000 | -77.8% | 6,044 | -68.2% | 0.02% | -76.5% |
| Q3 2021 | $2,209,000 | +44.8% | 18,980 | +106.1% | 0.08% | +131.4% |
| Q2 2021 | $1,526,000 | +355.5% | 9,207 | +283.6% | 0.04% | +250.0% |
| Q1 2021 | $335,000 | +9.5% | 2,400 | +9.1% | 0.01% | -75.0% |
| Q3 2020 | $306,000 | – | 2,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |